Gastroenterology
Volume 134, Issue 5 , Pages 1612-1614 , May 2008

Liver Transplantation for Hepatocellular Carcinoma: Who Benefits and Who Is Harmed?

  • Michael Volk
  • ,
  • Jorge A. Marrero

      Affiliations

    • Corresponding Author InformationAddress requests for reprints to: Jorge A. Marrero, MD, MS, Division of Gastroenterology, 3912 Taubman Center SPC 5362, Ann Arbor, MI 48109.

  • Image Result

    The number of liver transplantations from 1997 to 2006 for Hepatocellular Carcinoma according to United Network of Organ Sharing regions. Region 1 = Maine, Eastern Vermont, New Hampshire, Connecticut,

    The number of liver transplantations from 1997 to 2006 for Hepatocellular Carcinoma according to United Network of Organ Sharing regions. Region 1 = Maine, Eastern Vermont, New Hampshire, Connecticut, Massachusetts, and Rhode Island. Region 2 = Delaware, District of Columbia, Maryland, New Jersey, Pennsylvania, and West Virginia. Region 3 = Florida, Georgia, Alabama, Mississippi, Louisiana, Arkansas, and Puerto Rico. Region 4 = Texas, Oklahoma. Region 5= Arizona, California, Nevada, New Mexico, and Utah. Region 6 = Alaska, Hawaii, Idaho, Montana, Oregon, and Washington. Region 7 = Illinois, Minnesota, North Dakota, South Dakota, and Wisconsin. Region 8 = Colorado, Iowa, Kansas, Missouri, Nebraska, and Wyoming. Region 9 = New York and Western Vermont. Region 10 = Indiana, Ohio, and Michigan. Region 11 = Kentucky, North Carolina, South Carolina, Tennessee, and Virginia.

PII: S0016-5085(08)00536-2

doi: 10.1053/j.gastro.2008.03.042

Gastroenterology
Volume 134, Issue 5 , Pages 1612-1614 , May 2008